We supplemented the B-cell growth media with adenosine, guanosine, cytosine, uridine and thymidine (AGCTU) concurrent with EBV infection and this led to an increase in the number of CD19+ proliferating B cells at day 14 post infection relative to untreated cells (Figure 4b). The gene discussed is CD19; the disease is infection.